Genmab A/SGMABNASDAQ

Revenue (LTM)

$23.7B

+10.2% YoY

Net Income (LTM)

$6.1B

-21.7% YoY

Free Cash Flow

$7.3B

Revenue CAGR (5Y)

+18.6%

Marginsdeclining

FCF$7.3B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	8,417	14,505↑72.3%	16,474↑13.6%	21,526↑30.7%	23,728↑10.2%
Gross Profit	8,417	14,505↑72.3%	16,248↑12.0%	20,541↑26.4%	21,757↑5.9%
Operating Income	2,953	6,267↑112.2%	5,321↓15.1%	6,703↑26.0%	7,973↑18.9%
Net Income	2,957	5,452↑84.4%	4,352↓20.2%	7,844↑80.2%	6,143↓21.7%
EBITDA	4,181	7,346↑75.7%	5,947↓19.0%	9,697↑63.1%	8,426↓13.1%
EPS Diluted	4.48	8.26↑84.4%	6.60↓20.1%	12.14↑83.9%	9.79↓19.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	8,957	9,893↑10.4%	14,867↑50.3%	9,858↓33.7%	10,906↑10.6%
Total Current Assets	22,736	28,218↑24.1%	33,139↑17.4%	27,854↓15.9%	18,346↓34.1%
Total Assets	24,627	30,119↑22.3%	35,289↑17.2%	45,811↑29.8%	81,859↑78.7%
Total Current Liabilities	1,568	1,823↑16.3%	2,484↑36.3%	5,308↑113.7%	9,074↑71.0%
Total Liabilities	2,431	2,837↑16.7%	3,679↑29.7%	9,114↑147.7%	44,678↑390.2%
Total Equity	22,196	27,282↑22.9%	31,610↑15.9%	36,697↑16.1%	37,181↑1.3%
Total Debt	425	597↑40.5%	770↑29.0%	1,029↑33.6%	35,356↑3335.9%
Net Debt	-8,532	-9,296↓9.0%	-14,097↓51.6%	-8,829↑37.4%	24,450↑376.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	2,228	3,912↑75.6%	7,380↑88.7%	7,771↑5.3%	7,565↓2.7%
Capital Expenditure	-252	-317↓25.8%	-376↓18.6%	-187↑50.3%	-236↓26.2%
Free Cash Flow	1,976	3,595↑81.9%	7,004↑94.8%	7,584↑8.3%	7,329↓3.4%
Stock-Based Comp	310	439↑41.6%	586↑33.5%	721↑23.0%	0
Net Change in Cash	1,697	936↓44.8%	4,974↑431.4%	-5,009↓200.7%	2,201↑143.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance